Getein1600 Successfully Registered in Mexico!   We are thrilled to announce that Getein 1600, our highly versatile immunofluorescence analyzer, has successfully completed the registration process in Mexico, marking an important milestone in our journey of expanding global healthcare solutions.This achievement would not have been possible without the tremendous support from our esteemed client, whose dedication and collaboration played a vital role in ensuring a smooth and successful registration process. Their valuable insights and local expertise helped us navigate the regulatory landscape, ensuring that Getein1600 meets the stringent standards and requirements of the Mexican health authorities.   Why Getein 1600? Getein1600 is designed to deliver fast, reliable, and precise results, making it an ideal choice for laboratories and healthcare facilities. Its advanced  immunofluorescence  technology allows for high sensitivity and accuracy in detecting a wide range of biomarkers. From routine diagnostics to specialized testing, Getein1600 is equipped to handle it all, providing clinicians with the data they need to make informed decisions and improve patient care.     Key features include: Rapid Testing Get results in as little as 3-15 minutes. High Throughput Capable of processing up to 150 tests per hour. Comprehensive Test Menu Covering critical areas such as cardiology, endocrinology, and infectious diseases. User-Friendly InterfaceIntuitive design for ease of use in any laboratory setting.   A Step Towards Improved Healthcare in Mexico This registration opens the door for healthcare providers across Mexico to access cutting-edge diagnostic technology, enabling faster and more accurate diagnoses. We are excited about the opportunity to contribute to the enhancement of healthcare standards in Mexico and to partner with local healthcare professionals in delivering better outcomes for patients.     Once again, we extend our heartfelt thanks to our client for their invaluable assistance and trust in our products. We look forward to continued collaboration and success as we expand our reach in Mexico and beyond.Stay tuned for more updates and innovations from Getein as we continue to push the boundaries of diagnostic excellence!  

BSI Delegation Visited Getein, Discussing New Cooperation     On September 5th, Michael Weissig, General Manager of the Medical Device Business of BSI (British Standards Institution), and his team visited Getein Biotech, aiming to conduct in-depth discussions on international certification and market access of medical device products. The core management team of BSI's medical device business headquarters, business leaders in the Asia-Pacific and China regions, together with the senior team represented by Dr. Enben Su, General Manager of Getein Biotech, and international trade team, attended the event.     Introduction of BSI Founded in 1901, BSI, full name British Standards Institution, is the world's first national standards organization and currently an authoritative commercial standards company internationally. BSI is a key member of the International Organization for Standardization (ISO), the International Electrotechnical Commission (IEC), and the European Committee for Standardization (CEN), and plays an important role in these organizations. Through formulating and promoting standards, providing product testing and certification services, conducting enterprise quality system certification, and participating in international standardization activities, BSI provides high-quality standardization services to global enterprises and government agencies.     BSI Visited Getein’s Manufacturing Center The event began with a comprehensive and in-depth visit to our company. We led the BSI team to visit the company's exhibition hall, reagent production workshop, instrument production workshop, and injection molding workshop respectively. During the introduction of the products in the exhibition hall, Mr. Alex Laan, Head of BSI IVD Notified Body, spoke highly of our company's full industrial layout of product lines, the diversity of products covering different medical needs, and the degree of product innovation. During the visit to the production workshops, the BSI team expressed their approval of our company's production scale and the standardization of the production process. Subsequently, both parties moved to the conference room and conducted in-depth and fruitful talks on business cooperation and future development.     Getein Biotech Deepens Partnership with BSI   Getein Biotech and BSI have formed a close strategic partnership through years of cooperation. During this meeting, Dr. Enben Su, General Manager of Getein Biotech, and Dr. Michael Weissig reviewed the previous cooperation between the two parties and introduced their respective work progress in detail. Both sides fully exchanged views on topics such as the prospects of the medical device industry and the current IVDR quality management system, and expressed their desire to deepen cooperation and strengthen communication. After introducing Getein Biotech's development in recent years, the BSI team highly recognized the achievements and ...

Riding the Waves, Shining Brightly       [Live from the Exhibition - Witness Technological Advances] The 76th Annual Meeting of the American Association for Clinical Chemistry and Clinical Lab Expo (ADLM) has already opened successfully . As the highest quality and largest annual event in the field of clinical laboratory testing worldwide, this year's exhibition featured more than 900 leading companies from over 110 countries showcasing their products and services. As one of the world's leading professional medical exhibitions, ADLM has garnered unanimous recognition from international exhibitors, customers, and experts alike, for both its scale and its potential market benefits. The exhibition's value is self-evident.         [Highlighted Products -Making a Strong Entrance]   Getein Biotech sailed into this land of technological innovation and vitality once more, showcasing its excellent and outstanding innovative solutions, and engaging in discussions with global partners. The booth presented a range of POCT, immunofluorescence, and Getein Animal products. During this event, our chemiluminescence flagship product, MAGICL 6000, and renowned POCT product, Getein 1160, attracted numerous professionals for viewing and discussions, receiving high praise. The molecular diagnostic instrument GN 7000 and Getein 1100 Vet from Getein's animal series also amazed the audience, who expressed great anticipation for Getein Biotech's technology and new products.     Getein's staff on site, with enthusiastic demeanor and professional expertise, meticulously explained Getein's outstanding innovative solutions and renowned flagship products to the visitors, showcasing Getein's cutting-edge technological progress to the world.     We extend our heartfelt gratitude to all the experts and peers who visited our booth. Your interactions and exchanges infused us with boundless motivation and inspiration. In the future, Getein Biotech will adhere to its original mission, continuously improve product quality, advance product application and development, actively embrace the global market, and continue to collaborate closely with our customers, jointly composing a new chapter in medical technology!